NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Huatai Peptide? Mail in a sample (US only) and let us test it.

Test my supply
72%
Finnrick rating
#263 of 457 ranked vendors
6 of 12 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Huatai Peptide's current purity-focus record is narrow and centered on Retatrutide, with identity generally intact but the clean purity/fill signal isolated. Later Retatrutide results show repeated purity misses and a large underfill, while uneven batch documentation and limited peptide breadth keep the evidence uncertain despite recent testing.

methodology →
vendor intelligence report
Vendor Intelligence Report: Huatai Peptide

Domain and certificate records put Huatai's storefront much younger than its long-history marketing, with sister-domain and Hostinger staging artifacts muddying the operator trail. The report also tracks copied QC content, unresolved COA verification, and crypto/Wise recourse risk.

21 pages6 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%7 Jan 2026: 72%7 Jan 2026: 69%18 Feb 2026: 72%22 Feb 2026: 67%26 Feb 2026: 63%26 Feb 2026: 59%2 Mar 2026: 70%3 Mar 2026: 68%30 Jul 2026: 70%6 Aug 2026: 71%6 Aug 2026: 72%6 Aug 2026: 72%7 Oct 2026: current 72%72%72%Jan 26Oct 26
Free peptide testing

Ordered peptides from Huatai Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Huatai Peptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
6 Aug 2026
Pass
Retatrutide
lab nameView COA
6 Aug 2026
Pass
Retatrutide
lab nameView COA
6 Aug 2026
Pass
Tirzepatide
lab nameView COA
30 Jul 2026
Pass
Retatrutide
lab nameView COA
3 Mar 2026
Fail
Retatrutide
lab nameView COA
2 Mar 2026
Pass
Tirzepatide
lab nameView COA
26 Feb 2026
Fail
Retatrutide
lab nameView COA
26 Feb 2026
Fail
Retatrutide
lab nameView COA
22 Feb 2026
Fail
Retatrutide
lab nameView COA
18 Feb 2026
Pass
Retatrutide
lab nameView COA
1-10 of 12

About Huatai Peptide test results from Finnrick

Huatai Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 12 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Huatai Peptide peptides in this dataset are Retatrutide (10 tests), Tirzepatide (2 tests) and Tesamorelin (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 12 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Huatai Peptide? Mail in a sample (US only) and let us test it.

Test my supply